TY  - GEN
AU  - Pang,Li-ping
AU  - Huang,Wei
AU  - Sun,Qi
AU  - Guo,Wei
AU  - Li,Run-tao
AU  - Cui,Jing-rong
TI  - SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells
SN  - 0959-4973
PY  - 2008///0407
KW  - Animals
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - Blotting, Western
KW  - CDC2-CDC28 Kinases
KW  - genetics
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Cyclin B
KW  - Cyclin B1
KW  - Cyclophosphamide
KW  - Dose-Response Relationship, Drug
KW  - Flow Cytometry
KW  - G2 Phase
KW  - Gene Expression
KW  - Injections, Intraperitoneal
KW  - Leukocyte Count
KW  - Liver Neoplasms, Experimental
KW  - Male
KW  - Mice
KW  - Mice, Inbred ICR
KW  - Molecular Structure
KW  - Piperazines
KW  - RNA, Messenger
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - S Phase
KW  - Weight Loss
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/CAD.0b013e3282f2885f
ER  -